Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

By Drug Class (Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region and Competition

Published	Pages	Publisher	Report code
Oct 2023	178	TechSci Research	ASDR-637919

Published: Oct 2023 - Pages : 178 - Publisher : TechSci Research - Report code : ASDR-637919

1. Gilead Sciences Inc
2. Novartis AG
3. Pfizer Inc.
4. Merck & Co. Inc.
5. GlaxoSmithKline plc
6. F. Hoffmann-La Roche Ltd.
7. CTI BioPharma Corp.
8. Celltrion Healthcare Co. Ltd.
9. Bristol Myers Squibb Company
10. AbbVie Inc

$Refractory Follicular Lymphoma Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F$

This report can be of interest as well:

Refractory Follicular Lymphoma Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-...

Published: December, 2024 | Report code: ASDR-671770